Picture of LAVA Therapeutics NV logo

LVTX — LAVA Therapeutics NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: LAVA Therapeutics Q3 basic EPS USD -0.34

Nov 16 (Reuters) - LAVA Therapeutics Q3 net income USD -8.836 million.
* Q3 basic EPS USD -0.34
* Q3 pretax profit USD -8.786 million
* Q3 gross profit USD 43 thousand
* Q3 operating income USD -10.727 million
* Q3 operating expenses USD -10.77 million

Recent news on LAVA Therapeutics NV

See all news